• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Aktiia gets FDA clearance for OTC cuffless blood pressure monitor

July 7, 2025
in Medical Research
Reading Time: 3 mins read
A A
0
Aktiia gets FDA clearance for OTC cuffless blood pressure monitor
2
SHARES
4
VIEWS
Share on FacebookShare on Twitter



Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band. 

Aktiia’s blood pressure system, known under the Hilo brand in Europe, is a wearable that uses an optical sensor to collect data from one’s wrist. That data is then sent to the Hilo app and Hilo’s cloud server, where algorithms estimate the wearer’s blood pressure using pulse wave analysis. 

The company says the analysis examines the unique form of pressure exerted by each heartbeat through the wearer’s blood vessels. 

The wrist wearable continuously collects one’s blood pressure throughout the day, but does so only when they are still.

The product, which is already CE marked as a Class IIa medical device for monitoring blood pressure in adults in Europe, will be available to U.S. consumers in 2026. 

“This milestone is deeply personal for us as founders and profoundly important for everyone at Aktiia. From day one, our mission has been to tackle the global hypertension crisis through technology. With this FDA clearance, we’re one step closer to realizing our vision: a future where healthy blood pressure is accessible to all,” Dr. Josep Solà, cofounder and chief technology officer at Aktiia, told MobiHealthNews.

“What makes this moment truly historic is not just the clearance itself, but the fact that the FDA has approved the Aktiia device for over-the-counter use, no prescription required. It’s a rare and demanding bar to meet, and a clear signal that our technology is not only clinically validated but ready for real-world, large-scale deployment.”

Dr. Mattia Bertschi, cofounder and CEO, told MobiHealthNews that the FDA clearance helps the company expand its reach.

“This opens a new market for us, but more importantly, it confirms that Aktiia’s solution is safe, intuitive, and designed for the people who need it most. We believe this is just the beginning, and that cuffless, wearable, and over-the-counter blood pressure monitoring will soon become the global standard,” Bertschi said. 

“We’re working day and night to ensure that Hilo by Aktiia doesn’t just participate in this transformation… but leads it.”

THE LARGER TREND

In May, Aktiia scored $42 million in an oversubscribed Series B funding round, bringing its total raise to more than $100 million. 

Last year, Aktiia completed a CHF 27 million ($30 million) funding round and received CE mark in Europe for its calibration-free technology CALFREE, which allows blood pressure data to be collected using inputs from optical sensors commonly found in smartwatches and cameras of commercial smartphones. 

The Swiss company said that approval of its CALFREE tech would enable it to offer integration of its medical-grade optical blood pressure monitoring to third-party companies developing consumer devices, such as smartwatches, smartphone cameras, and smart bands.

In 2021, the company raised $17.5 million in Series A funding, and the year before, it secured $6.1 million (CHF 6 million) in funding.

The company, founded in 2018, was a spin-out of CSEM, a Swiss research and development center.




Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band. 

Aktiia’s blood pressure system, known under the Hilo brand in Europe, is a wearable that uses an optical sensor to collect data from one’s wrist. That data is then sent to the Hilo app and Hilo’s cloud server, where algorithms estimate the wearer’s blood pressure using pulse wave analysis. 

The company says the analysis examines the unique form of pressure exerted by each heartbeat through the wearer’s blood vessels. 

The wrist wearable continuously collects one’s blood pressure throughout the day, but does so only when they are still.

The product, which is already CE marked as a Class IIa medical device for monitoring blood pressure in adults in Europe, will be available to U.S. consumers in 2026. 

“This milestone is deeply personal for us as founders and profoundly important for everyone at Aktiia. From day one, our mission has been to tackle the global hypertension crisis through technology. With this FDA clearance, we’re one step closer to realizing our vision: a future where healthy blood pressure is accessible to all,” Dr. Josep Solà, cofounder and chief technology officer at Aktiia, told MobiHealthNews.

“What makes this moment truly historic is not just the clearance itself, but the fact that the FDA has approved the Aktiia device for over-the-counter use, no prescription required. It’s a rare and demanding bar to meet, and a clear signal that our technology is not only clinically validated but ready for real-world, large-scale deployment.”

Dr. Mattia Bertschi, cofounder and CEO, told MobiHealthNews that the FDA clearance helps the company expand its reach.

“This opens a new market for us, but more importantly, it confirms that Aktiia’s solution is safe, intuitive, and designed for the people who need it most. We believe this is just the beginning, and that cuffless, wearable, and over-the-counter blood pressure monitoring will soon become the global standard,” Bertschi said. 

“We’re working day and night to ensure that Hilo by Aktiia doesn’t just participate in this transformation… but leads it.”

THE LARGER TREND

In May, Aktiia scored $42 million in an oversubscribed Series B funding round, bringing its total raise to more than $100 million. 

Last year, Aktiia completed a CHF 27 million ($30 million) funding round and received CE mark in Europe for its calibration-free technology CALFREE, which allows blood pressure data to be collected using inputs from optical sensors commonly found in smartwatches and cameras of commercial smartphones. 

The Swiss company said that approval of its CALFREE tech would enable it to offer integration of its medical-grade optical blood pressure monitoring to third-party companies developing consumer devices, such as smartwatches, smartphone cameras, and smart bands.

In 2021, the company raised $17.5 million in Series A funding, and the year before, it secured $6.1 million (CHF 6 million) in funding.

The company, founded in 2018, was a spin-out of CSEM, a Swiss research and development center.


Previous Post

Low doses of CBD may cause harm to the liver, FDA study finds

Next Post

This Week in Astronomy with Dave Eicher: The Moon passes Antares

Related Posts

biomarker research

Treatment decisions on basis of biomarker-based test can be harmful

July 7, 2025
5
Study reveals accurate association between weak handgrip and a host of diseases among over-50s

Study reveals accurate association between weak handgrip and a host of diseases among over-50s

July 7, 2025
5
Next Post
This Week in Astronomy with Dave Eicher: The Moon passes Antares

This Week in Astronomy with Dave Eicher: The Moon passes Antares

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Police ID man who died after Corso Italia fight

December 23, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0

CSA invest $3.9 million in five smartEarth proposals

July 7, 2025
biomarker research

Treatment decisions on basis of biomarker-based test can be harmful

July 7, 2025
California, 17 other states challenge 'suspicionless' stops by masked ICE agents in L.A.

California, 17 other states challenge ‘suspicionless’ stops by masked ICE agents in L.A.

July 7, 2025

MAGA influencers fume over DOJ’s Epstein memo

July 7, 2025

Recent News

CSA invest $3.9 million in five smartEarth proposals

July 7, 2025
2
biomarker research

Treatment decisions on basis of biomarker-based test can be harmful

July 7, 2025
5
California, 17 other states challenge 'suspicionless' stops by masked ICE agents in L.A.

California, 17 other states challenge ‘suspicionless’ stops by masked ICE agents in L.A.

July 7, 2025
3

MAGA influencers fume over DOJ’s Epstein memo

July 7, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

CSA invest $3.9 million in five smartEarth proposals

July 7, 2025
biomarker research

Treatment decisions on basis of biomarker-based test can be harmful

July 7, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co